← Back to Events
Tier 1 Global Networking: High GENERAL CONCLUDED
ASGCT Annual Meeting — 2026 — Boston, USA
Annual meeting of the American Society of Gene & Cell Therapy bringing together professionals to advance CGT science, technology, and application with new research and translation approaches.
2 Presentations
1 Companies
Presentation data updated Jun 5, 2026, 11:21 AM UTC
Nova Event Impact Score
56 /100
- Media coverage 20/20
- Speaker quality 14/20
- Pipeline relevance 0/20
- Historical influence 20/20
- Company participation 2/20
Key Takeaways
Key Themes
generalAmerican Society of Gene & Cell Therapy (ASGCT)Pipeline announcementsPartnership deals
Key Companies
Ascidian Therapeutics
Key Markets
US Americas
Key Opportunities
Partnership dealsLicensing discussionsVendor selection
Investors & analysts
Key Data to Watch
POSTER
POLARIS program: Phase 1/2 open-label, dose-escalation studies—ENDEAVOR (USA, NCT05419492), WAYFINDER (AUS, NCT06112275), EXPEDITION
PRESENTATION
Initial human safety data from RNA exon editing platform in Stargardt disease